Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
BMC Public Health|March 15, 2018
Can knowledge exchange support the implementation of a health-promoting schools approach? Perceived outcomes of knowledge exchange in the COMPASS studyKristin M Brown, Susan J Elliott, Jennifer Robertson-Wilson, et al.
Health Promotion Practice|September 21, 2017
"Now What?" Perceived Factors Influencing Knowledge Exchange in School Health ResearchKristin M Brown, Susan J Elliott, Jennifer Robertson-Wilson, et al.
American Journal of Respiratory Cell and Molecular Biology|July 17, 2004
Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungsPhilippe Bonniaud, Gail Martin, Peter J Margetts, et al.
American Journal of Respiratory and Critical Care Medicine|June 21, 2003
Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosisPhilippe Bonniaud, Peter J Margetts, Martin Kolb, et al.
American Journal of Infection Control|July 25, 2016
Using expert process to combat Clostridium difficile infectionsIsabelle Guerreiro, Camille Achonu, Grace Volkening, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureusDerry K Mercer, Laura K Katvars, Fiona Hewitt, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|December 22, 2017
Modified sprint interval training protocols: physiological and psychological responses to 4 weeks of trainingGreg L McKie, Hashim Islam, Logan K Townsend, et al.
Orphanet Journal of Rare Diseases|December 1, 2014
Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosisCedric Charrier, Catherine Rodger, Jennifer Robertson, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy CandidateDerry K Mercer, Colin S Stewart, Lorna Miller, et al.
Hospital Pediatrics|May 8, 2024
Optimizing the Use of Dose Error Reduction Software on Intravenous Infusion PumpsKristen Hughes, Madison Cole, Deann Tims, et al.
Pageof 8